October 2022 PMID 36027563

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.

Divaka Perera, Tim Clayton, Peter D O'Kane, John P Greenwood, Roshan Weerackody, Matthew Ryan, Holly P Morgan, Matthew Dodd, Richard Evans, Ruth Canter, Sophie Arnold, Lana J Dixon, Richard J Edwards, Kalpa De Silva, James C Spratt

Full text PDF Download social card

Mentions

260

Peak: 39 in Dec 2022

across 6 sources since Aug 2022

Extended reach

706,680

potential audience

Total likes

353

Video views

1,782

Mentions per month

Aug 2022 – Jun 2025

Where it's discussed

X / Twitter197 posts
News44 articles
Blogs9 articles
YouTube4 videos
Facebook4 posts
Reddit2 posts

AI synopsis

What people are saying

The conversations surrounding the publication highlight key findings, such as the fact that 'PCI did not best OMT in REVIVED-BCIS2' and 'there wasn't a lower incidence of death or hospitalization due to heart failure with intervention.' Comments like 'another failure of stenting to show a benefit' reflect the disappointment among healthcare professionals regarding PCI's effectiveness. The choice of words and a somewhat critical tone throughout these discussions emphasize the research's relevance, while comments posing further questions point to a desire for clarity and deeper understanding in the medical community.

AgreementModerate agreement

Many discussions express a consensus on the outcomes showing minimal benefit from PCI, reflecting a moderate agreement with the study's findings.

InterestHigh interest

The overall curiosity about the findings and their implications for clinical practice is evident, as users frequently share insights and ask questions.

EngagementModerate engagement

While most discussions focus on summarizing the publication, some delve deeper into its clinical significance and implications, indicating moderate engagement.

ImpactHigh impact

There is a strong belief that the study will influence future medical decisions and practices concerning ischemic heart disease.

Abstract in brief

The study explores whether percutaneous coronary intervention (PCI) can enhance survival and heart function in patients with severe ischemic left ventricular dysfunction compared to standard medical therapy.
700 patients with a left ventricular ejection fraction of 35% or lower were randomly assigned to receive either PCI in combination with optimal medical therapy or optimal medical therapy alone.
Results showed no significant difference in the rates of death or heart failure hospitalization between the two groups, and while quality of life scores initially favored the PCI group, the difference diminished over time.

Read the full abstract

All mentions

Comparison of Transcatheter and Surgical Aortic Valve Replacement in Low-Risk Patients

This study compares long-term outcomes of TAVR and SAVR in low-risk patients with severe aortic stenosis, showing TAVR reduces death risk by 20% over five years with similar stroke rates.

Medscape · Mar 7, 2025 690 views

Advances in Class 1C Antiarrhythmic Use for Heart Failure Patients

This week's podcast covers topics including Inclisiran updates, sodium channel blockers, and analytic flexibility in research. The study on class 1C antiarrhythmics shows they can reduce PVCs and improve heart function…

Medscape · May 10, 2024 626 views

Percutaneous Revascularization and Patient Outcomes in Cardiology

The video discusses the latest findings in cardiology, including an Impella update, the TAVI vs SAVR trial, and studies on angina and PCI. Focused on percutaneous coronary intervention, it examines its impact on…

Medscape · May 17, 2024 428 views

Insights on PCI for Ischemic Left Ventricular Dysfunction Trends

This week, John Mandrola MD discusses key findings on whether percutaneous coronary intervention enhances survival and heart function in patients with severe ischemic left ventricular dysfunction compared to standard…

Medscape · Mar 27, 2024 26 views

Top Ten Cardiology Stories of 2022 with Key Insights

This podcast reviews the top ten cardiology stories of 2022, focusing on major trials and findings, including insights from the study on percutaneous coronary intervention (PCI) for ischemic left ventricular…

Medscape · Mar 27, 2024 14 views

Jay Mathews MD, MS, FACC, FSCAI

@JayMathewsMD · X

@VictorDayan1 @mmamas1973 @DavidLBrownMD @FaisalBakaeen @pomyers @rafasadaba PCI did not best OMT in REVIVED-BCIS2 https://t.co/QKbNtMAHO7

Jun 4, 2025 · 1 like · 3,783 followers View post →

Willy Frick

@willyhfrick · X

Feb 5, 2025 · 21 likes · 4,037 followers View post →

Samuel Barreto

@Barreticos01 · X

RT @jsenior64: https://t.co/uzjrl2Ve8O

Jan 9, 2025 · 1 share · 541 followers View post →

Juan Senior

@jsenior64 · X

https://t.co/uzjrl2Ve8O

Jan 6, 2025 · 1 like · 1 share · 11,064 followers View post →

TT(腎臓内科×膠原病内科)

@TT58852391 · X

あと興味深かったのは、2022 NEJMの結果が少し反映されてそうな治療内容だったこと(https://t.co/yv1RuMlH27) 勉強になりますなぁ ※この論文の日本語纏め記事 https://t.co/ZrjQCQTQW0 https://t.co/Z6apgeTQNP

Dec 16, 2024 · 7 likes · 7,877 followers View post →

Christian Caroli

@DrCCaroli · X

Sep 22, 2024 · 2 likes · 2,407 followers View post →

Augusto Rojas Carrión

@AugustoR04 · X

RT @DrCCaroli:

Jul 19, 2024 · 1 share · 329 followers View post →

Christian Caroli

@DrCCaroli · X

Jul 17, 2024 · 4 likes · 1 share · 2,407 followers View post →

DocHubee

@DocHubee · X

RT @DocHubee: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction | New England Journal of Medicine https://t.co/q0ZJA…

Jun 24, 2024 · 1 share · 554 followers View post →

DocHubee

@DocHubee · X

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction | New England Journal of Medicine https://t.co/q0ZJACZIfA

Jun 24, 2024 · 1 like · 1 share · 554 followers View post →

UCL Discovery

@ucl_discovery · X

Open Access UCL Research: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial https://t.co/UTHvkAGOwe

Apr 15, 2024 · 2,528 followers View post →

Giuseppe Biondi-Zoccai

@gbiondizoccai · X

@sam_szarbiv @SaidAshrafMD @BinitaShahMD @SripalBangalore @LouaiRazzouk @SVRaoMD @NSmilowitzMD @HashimHayder @MohitpahujaMD @DrAmirKaki @SrihariNaiduMD @mmamas1973 The issue is not what I think, but what the evidence shows. Please peruse more attentively the REVIVED-BCIS 2 results. Do they apply to such patients or not? https://t.co/xVSdakOqa7

Mar 26, 2024 · 1 like · 12,113 followers View post →

フロシンキ

@hurosinki · X

元論文 https://t.co/NzXX61Ipqx https://t.co/CE6JoP0Mij

Feb 8, 2024 · 330 followers View post →

sajannarayanan

@sajannarayanan · X

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial | Circulation: Cardiovascular Quality and Outcomes https://t.co/OIOpYpqty6

Jan 30, 2024 · 964 followers View post →

Matias Rodriguez G

@matiasrg · X

@drjohnm IMHO there weren't the best candidates for revascularization with stent. Read supp material please. 56% prox LAD and 2 median number of treated lesions per pt in PCI group. This seems to me pts with poor LVEF & CAD but not because of CAD. https://t.co/QzVlMYYML1 https://t.co/mu4Jq6lVzB

Jan 23, 2024 · 3 likes · 1,391 followers View post →

SFC - Société Française de Cardiologie

@SFCardio · X

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial

Jan 22, 2024 · 4,709 followers View post →

Timir Paul, MD, PhD, FACC, FSCAI, FAHA

@timir_paul · X

RT @theindianheart: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction

Dec 20, 2023 · 1 share · 6,217 followers View post →

Indian Heart Association

@theindianheart · X

Full article open access #FOAMed: https://t.co/7373GjW6no

Dec 19, 2023 · 1 like · 1,117 followers View post →

Indian Heart Association

@theindianheart · X

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction

Dec 19, 2023 · 7 likes · 1 share · 1,117 followers View post →

Amir Lotfi

@AmirLotfi9 · X

@ctinocomesquita @mdicarli @NeivaMaciel_doc @SIAC_cardio @almallahmo @roxanacampisi @MyASNC @rafaelnuclear @ap08891516 @JACCJournals @JNCjournal @Ggrossman11 https://t.co/nFHP0hiY0D https://t.co/b7nMQReUQJ

Nov 19, 2023 · 392 followers View post →

Long Island Fellows Forum

@LongIslandFF · X

RT @GiorgioMedranda: @SVRaoMD @djc795 @rwyeh happens more often than we appreciate, maybe why this was a negative study…https://t.co/lVxVba…

Nov 6, 2023 · 2 shares · 483 followers View post →

Capitol Fellows Forum

@CapitolFF · X

RT @GiorgioMedranda: @SVRaoMD @djc795 @rwyeh happens more often than we appreciate, maybe why this was a negative study…https://t.co/lVxVba…

Nov 6, 2023 · 2 shares · 402 followers View post →

Giorgio A. Medranda MD, FACC, FAHA, FSCAI

@GiorgioMedranda · X

@SVRaoMD @djc795 @rwyeh happens more often than we appreciate, maybe why this was a negative study…https://t.co/lVxVba4C0G

Nov 6, 2023 · 6 likes · 2 shares · 1,915 followers View post →

Caspian Kuma Folmsbee MD

@FolmsbeeMD · X

https://t.co/yIOBFJAW1k

Nov 4, 2023 · 291 followers View post →

Gustavo González

@gustavado11 · X

RT @javier20ch: Revascularización percutánea para la disfunción ventricular izquierda isquémica (REVIVED-BCIS2).

Sep 2, 2023 · 3 shares · 129 followers View post →

Doctor's Eye

@DrSanaullah18 · X

RT @USMLEStepStudy: Among patients with severe ischemic left ventricular systolic dysfunction who received optimal medical therapy, revascu…

Aug 7, 2023 · 1 share · 395 followers View post →

StudyXing Medicine

@USMLEStepStudy · X

Among patients with severe ischemic left ventricular systolic dysfunction who received optimal medical therapy, revascularization by stents did not result in a lower incidence of death from any cause or hospitalization for heart failure https://t.co/Vdo7TpP7QI

Aug 7, 2023 · 9 likes · 1 share · 56,430 followers View post →

Jeff Davis, MD

@jeffdavismd · X

Another failure of stenting to show a benefit vs oral therapy? Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction | NEJM https://t.co/T649oEQ8YM

Aug 7, 2023 · 1 like · 6,296 followers View post →

Mohsin Furqan

@MM_Furqan · X

REVIVED Trial: Revascularization by PCI did not result ⬇️ death from any cause or hospitalization for HF in pts with severe ischemic LV systolic dysfunction who received optimal medical therapy. https://t.co/da3qfA8hV0 #MedEd #MedX #MedTwitter #CardioTwitter #CardioX

Aug 5, 2023 · 2 likes · 244 followers View post →

Reza Ghanavati, MD.

@Ghanavati_r · X

3/n In

Jul 24, 2023 · 325 followers View post →

CardioTwit

@Goli_Bot · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 29, 2023 · 12 shares · 163 followers View post →

Luis Ortega Paz

@Ortega_Paz · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 26, 2023 · 12 shares · 3,926 followers View post →

Dr.Sultan Matar

@sul1mat · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 25, 2023 · 12 shares · 138 followers View post →

Islam Ibrahim

@Islam3dnan · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 25, 2023 · 12 shares · 66 followers View post →

Meetoo

@Meetoo87865396 · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 25, 2023 · 12 shares · 22 followers View post →

Sunshine & Sand

@GidaNadhira · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 25, 2023 · 12 shares · 21 followers View post →

Lis Mendez

@lismendez · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 25, 2023 · 12 shares · 1,892 followers View post →

JorgeEdoChava75

@QicenoJorge · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 25, 2023 · 12 shares · 994 followers View post →

DrPatWJyg

@w_jyg · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 25, 2023 · 12 shares · 3,082 followers View post →

Segun Olusanya (He/Him) iceman_ex@critcare.social

@iceman_ex · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 25, 2023 · 12 shares · 19,584 followers View post →

MIЯVΛƬ #IC ༄ ｡°

@mirvatalasnag · X

RT @PCRonline: Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunctio…

May 25, 2023 · 12 shares · 26,023 followers View post →

PCRonline

@PCRonline · X

Nine months on, how have the results of the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunction) trial

May 25, 2023 · 20 likes · 12 shares · 27,587 followers View post →

Wail AlkashkariFSCAI,FPICSوائل القشقرى

@AlkashkariWail · X

@QjsnpwIHzbdYKVF @bogamisa @DrAlsaiediAB @MogneeA @rashaalbawardy @ibrahimjelaidan @DFahadAlmehmadi @AlrahimiJ @merdadamd @abadkhan2002 https://t.co/vxC7MWcdFq

May 24, 2023 · 17,043 followers View post →

REVIVED

@REVIVED_BCIS2 · X

https://t.co/MeH3ImKIIL

May 20, 2023 · 976 followers View post →

Mark Petrie

@markcpetrie20 · X

RT @REVIVED_BCIS2: How has @REVIVED_BCIS2 affected clinical practice? Tune in to this session #euroPCR2023 at 1445 in room 241 today @ajayk…

May 17, 2023 · 8 shares · 1,285 followers View post →

Wail AlkashkariFSCAI,FPICSوائل القشقرى

@AlkashkariWail · X

RT @REVIVED_BCIS2: How has @REVIVED_BCIS2 affected clinical practice? Tune in to this session #euroPCR2023 at 1445 in room 241 today @ajayk…

May 17, 2023 · 8 shares · 17,043 followers View post →

Aish Sinha

@AishSinha1 · X

RT @REVIVED_BCIS2: How has @REVIVED_BCIS2 affected clinical practice? Tune in to this session #euroPCR2023 at 1445 in room 241 today @ajayk…

May 17, 2023 · 8 shares · 489 followers View post →

A.Nazmi Calik

@ANazmiCalik · X

RT @REVIVED_BCIS2: How has @REVIVED_BCIS2 affected clinical practice? Tune in to this session #euroPCR2023 at 1445 in room 241 today @ajayk…

May 17, 2023 · 8 shares · 3,901 followers View post →

Erik Rafflenbeul

@KardiologieHH · X

RT @REVIVED_BCIS2: How has @REVIVED_BCIS2 affected clinical practice? Tune in to this session #euroPCR2023 at 1445 in room 241 today @ajayk…

May 17, 2023 · 8 shares · 8,689 followers View post →

Holly

@hollymorgs · X

RT @REVIVED_BCIS2: How has @REVIVED_BCIS2 affected clinical practice? Tune in to this session #euroPCR2023 at 1445 in room 241 today @ajayk…

May 17, 2023 · 8 shares · 3,994 followers View post →

Divaka Perera

@divaka_perera · X

RT @REVIVED_BCIS2: How has @REVIVED_BCIS2 affected clinical practice? Tune in to this session #euroPCR2023 at 1445 in room 241 today @ajayk…

May 17, 2023 · 8 shares · 1,081 followers View post →

Cardiac Research

@UKheartresearch · X

RT @REVIVED_BCIS2: How has @REVIVED_BCIS2 affected clinical practice? Tune in to this session #euroPCR2023 at 1445 in room 241 today @ajayk…

May 17, 2023 · 8 shares · 1,235 followers View post →

REVIVED

@REVIVED_BCIS2 · X

May 17, 2023 · 22 likes · 8 shares · 976 followers View post →

Gudiya

@tahuworld · X

In patient with ischemia cardiomyopathy (EF < 35%) and viable myocardium, PCI led to no difference in Ejection Fraction, hospitalization or mortality at 2years when compared to Optimal Medical Therapy. #CardioTwitter https://t.co/2btGIzWHFA

May 3, 2023 · 3 followers View post →

Abdallah Al-Mohammad

@AAlMohammad87 · X

What a coincidence? #REVIVED trial @NEJM 2022: Death from any cause or hospitalisation for HF in 37% and 38% of those assigned to PCI and OMT, respectively. @BSHeartFailure @markcpetrie20 @Chestcracker #CardioTwitter @mmamas1973 https://t.co/OxfqnVyuuj

Apr 29, 2023 · 924 followers View post →

Abdallah Al-Mohammad

@AAlMohammad87 · X

3. #REVIVED showed neutral result with PCI in #HFrEF with CAD @NEJM #CardioTwitter @BSHeartFailure @mmamas1973 @TheresaMcDonag3 @markcpetrie20 DOI: 10.1056/NEJMoa2206606

Mar 25, 2023 · 1 like · 924 followers View post →

Mark Petrie

@markcpetrie20 · X

RT @MananPareekMD: Excellent morning report with VIP Professor Mark Petrie from @UofGlasgow taking us through the REVIVED-BCIS 2 trial. @Ri…

Mar 24, 2023 · 2 shares · 1,285 followers View post →

avazir

@avazir1 · X

RT @MananPareekMD: Excellent morning report with VIP Professor Mark Petrie from @UofGlasgow taking us through the REVIVED-BCIS 2 trial. @Ri…

Mar 24, 2023 · 2 shares · 393 followers View post →

Manan Pareek, MD, MSc, PhD, FAHA, FESC

@MananPareekMD · X

Excellent morning report with VIP Professor Mark Petrie from @UofGlasgow taking us through the REVIVED-BCIS 2 trial. @RigsHeart https://t.co/AangQybROa https://t.co/S9kz0grTBt

Mar 24, 2023 · 20 likes · 2 shares · 928 followers View post →

Prof. Biology

@ResearchBiology · X

The New England Journal of Medicine- Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction. https://t.co/yKYeyIXg56

Mar 19, 2023 · 568 followers View post →

Mauricio Marquez

@mauromarquezgal · X

RT @mandres80: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction | NEJM https://t.co/96frBU71m4 https://t.co/C4bYXZs…

Feb 20, 2023 · 1 share · 114 followers View post →

Manuel Garay-Fernández

@mandres80 · X

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction | NEJM https://t.co/96frBU71m4 https://t.co/C4bYXZsLV7

Feb 20, 2023 · 8 likes · 1 share · 2,278 followers View post →

Abdallah Al-Mohammad

@AAlMohammad87 · X

For more details of the #REVIVED trial @NEJM please look up @BSHeartFailure #cardiotwitter #CardioEd https://DOI: 10.1056/NEJMoa2206606

Feb 4, 2023 · 924 followers View post →

Professor M Z Khalil

@mzkhalil · X

Among patients with severe ischemic left ventricular systolic dysfunction who received OMT, revascularization by PCI did not result in a lower incidence of death from any cause or hospitalization for heart failure. | NEJM https://t.co/5dya4GbYrB https://t.co/Yh3AYfxrtC

Jan 27, 2023 · 1 like · 2,855 followers View post →

Linda

@wordfinga · X

RT @rahatheart1: #REVIVED: when invasive intervention is not warranted, it's best that pts are reprieved of such intrusion! @VictorDayan1 @…

Jan 21, 2023 · 5 shares · 4,597 followers View post →

Elio Martín Gutiérrez MD MsC PhD

@cirujano_cardio · X

RT @hollymorgs: Letters to the editor (and the authors reply) are now published @NEJM for @REVIVED_BCIS2. Very interesting reading! https:/…

Jan 18, 2023 · 5 shares · 238 followers View post →

Elio Martín Gutiérrez MD MsC PhD

@cirujano_cardio · X

RT @rahatheart1: #REVIVED: when invasive intervention is not warranted, it's best that pts are reprieved of such intrusion! @VictorDayan1 @…

Jan 18, 2023 · 5 shares · 238 followers View post →

Ovidio García

@ovidiogarciav · X

RT @rahatheart1: #REVIVED: when invasive intervention is not warranted, it's best that pts are reprieved of such intrusion! @VictorDayan1 @…

Jan 18, 2023 · 5 shares · 3,516 followers View post →

Victorio C. Carosella, MD. - ArgenSCORE

@Argenscore · X

RT @rahatheart1: #REVIVED: when invasive intervention is not warranted, it's best that pts are reprieved of such intrusion! @VictorDayan1 @…

Jan 18, 2023 · 5 shares · 2,431 followers View post →

Coronary 4Front

@Coronary4front · X

RT @rahatheart1: #REVIVED: when invasive intervention is not warranted, it's best that pts are reprieved of such intrusion! @VictorDayan1 @…

Jan 18, 2023 · 5 shares · 1,772 followers View post →

Rahat Warraich PhD

@rahatheart1 · X

#REVIVED: when invasive intervention is not warranted, it's best that pts are reprieved of such intrusion! @VictorDayan1 @pomyers @Coronary4front @ovidiogarciav @Argenscore @DocSavageTJU @GiuseppeGalati_ @MMarinCuartas @OPreventzaMD @SABOURETCardio @Hragy https://t.co/qpgeNpj1QC

Jan 18, 2023 · 15 likes · 5 shares · 10,785 followers View post →

Josh Wilcox

@jdrwilcox · X

RT @hollymorgs: Letters to the editor (and the authors reply) are now published @NEJM for @REVIVED_BCIS2. Very interesting reading! https:/…

Jan 18, 2023 · 5 shares · 1,139 followers View post →

Dr Peter O'Kane

@DrPeterOKane · X

RT @hollymorgs: Letters to the editor (and the authors reply) are now published @NEJM for @REVIVED_BCIS2. Very interesting reading! https:/…

Jan 17, 2023 · 5 shares · 3,697 followers View post →

Coronary 4Front

@Coronary4front · X

RT @hollymorgs: Letters to the editor (and the authors reply) are now published @NEJM for @REVIVED_BCIS2. Very interesting reading! https:/…

Jan 17, 2023 · 5 shares · 1,772 followers View post →

Kalyan Chitturi, DO, FACC

@KalChitturi · X

RT @hollymorgs: Letters to the editor (and the authors reply) are now published @NEJM for @REVIVED_BCIS2. Very interesting reading! https:/…

Jan 17, 2023 · 5 shares · 1,196 followers View post →

Holly

@hollymorgs · X

Letters to the editor (and the authors reply) are now published @NEJM for @REVIVED_BCIS2. Very interesting reading! https://t.co/p8B0r2Kjb9 @divaka_perera @DrMattRyan @DrPeterOKane #Cardiotwitter

Jan 17, 2023 · 17 likes · 5 shares · 3,994 followers View post →

naoya yanagi｜PT

@yanagi_PT_CR · X

8. REVIVED-BCIS2 Q. 虚血性心筋症患者において、PCIが指摘薬物療法（OMT）と比較して有益か？ 700例をPCI＋OMT群 vs OMT単独群に割付け ✅中央値41ヶ月間で主要アウトカム37% vs 38%と差はなし（元論文パネルD） ✅6ヶ月、12ヶ月でのLVEFに両群差はなし https://t.co/lwvkaaFmHH

Jan 6, 2023 · 2,266 followers View post →

Ernesto Duronto

@edurontoFF · X

@Dr_I3rahimSaleh @DLBHATTMD @ACCinTouch .Thank you.REVIVED-BCIS2 Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction should be included in this list.

Jan 2, 2023 · 1 like · 3,922 followers View post →

Kalpa De Silva

@K_DeSilva · X